Metabolomics

Dataset Information

0

Distinct metabolic profiles in lung adenocarcinomas presenting as solid or ground-glass opacities


ABSTRACT:

Metabolomic profiling provides real-time insights into tissue physiology and upstream molecular events. Despite its potential in cancer research, large-scale integrative studies in lung adenocarcinoma (LUAD) remain scarce. We analyzed 262 tissue samples from 165 LUAD patients using metabolomic, transcriptomic, and 16S rRNA sequencing, integrating data through a “gene-enzyme-reaction-metabolite” network. Distinct components of mixed ground-glass opacities (mGGOs) and lesions from multiple primary lung cancers (MPLC) were also evaluated separately. Our results revealed extensive metabolic reprogramming in LUAD, predominantly affecting glycerophospholipid metabolism. Pure ground-glass opacities (GGOs) and solid nodules (SNs) exhibited markedly distinct metabolic profiles, with linoleic acid metabolism as a key differentiator. In contrast, components within mGGOs were metabolically similar, resembling pure GGOs. Cellular and organoid models demonstrated that phospholipase A2 (PLA2) inhibition or phosphatidylcholine (32:0) treatment significantly attenuated invasion and proliferation of LUAD cells. These findings provide a metabolic basis for subtype-specific LUAD biology and potential therapeutic strategies.

INSTRUMENT(S): Liquid Chromatography MS - negative - reverse-phase, Liquid Chromatography MS - positive - reverse-phase

PROVIDER: MTBLS13565 | MetaboLights | 2025-12-23

REPOSITORIES: MetaboLights

Similar Datasets

2012-04-19 | GSE37351 | GEO
2012-04-18 | E-GEOD-37351 | biostudies-arrayexpress
| PRJNA1047533 | ENA
2018-11-17 | E-MTAB-6023 | biostudies-arrayexpress
2021-01-08 | E-MTAB-9387 | biostudies-arrayexpress
2011-07-06 | GSE26326 | GEO
| PRJNA839637 | ENA
2021-03-06 | GSE168352 | GEO
2016-11-05 | GSE74735 | GEO
2009-09-04 | GSE17929 | GEO